Janssen Biotech has agreed to acquire NYU spinout Benevir for a total of up $1.04bn, including $140m in an upfront payment.

Providence Ventures returned for behavioural health portal Lyra Health's series B round, taking its funding to more than $80m altogether.

Three months after raising $500m in a series G round, Moderna Therapeutics has secured $125m as part of a collaboration agreement with Merck & Co.

7wire Ventures' Connected Consumer Health Fund has secured a collection of healthcare and insurance providers as limited partners.

Vascugen has brought on-board more licences related to stem cell therapies that could restore blood vessels in tissues where the blood flow has been restricted.

Kirsten Stead and John Hamer of Monsanto Growth Ventures (MGV), the strategic investment arm of agribusiness Monsanto, which is being acquired by Germany-based peer Bayer, will co-manage the expected $250m fund, which is run by a new management company for the biotech space and affiliated with venture capital firm Data Collective (DCVC).

Google's Gradient Ventures unit was part of a series A round that will enable the biological research startup to boost its headcount.

The WuXi PharmaTech and Mayo Clinic-backed aging disease drug developer floated at the midpoint of its range.